Xuanzhu Biopharmaceutical Co., Ltd. (stock code: 02575) released its monthly return on movements in securities for the period ending November 30, 2025. According to the report, the total issued share capital remained at RMB 517,947,790, comprising 160,701,996 H shares and 357,245,794 unlisted shares. There were no changes in the number of shares nor any treasury shares during the reporting period, and no share options, warrants, or convertible instruments were outstanding. The company also confirmed that there were no Hong Kong Depositary Receipts or other arrangements for issuance of new shares in November 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments